JOINT MEMORIAL · 1993–94 SESSION
SJM 8007: Nonprescription drug categry
Petitioning Congress and the President to authorize the Federal Food and Drug Administration to study a transitional nonprescription drug category.
Summary
- The President and Congress are requested to authorize the Federal Drug Administration (FDA) to study a new transitional nonprescription drug category that designates drugs available for sale only through licensed pharmacists in order to evaluate for a specific period drugs being considered for over-the-counter release, with the goal to decrease the time needed for the FDA to approve a drug for over-the-counter…
From the Senate Bill Report (SJM 8007), written by the Legislature's nonpartisan staff. Read the full report ↗
Did not pass Did not pass · died in committee
- IntroducedJan 29, 1993
- Out of committeestopped here
- Passed Senate
- Passed House
- Filed
- Prime sponsor
- R. Lorraine Wojahn (D-27)
- Introduced
- January 29, 1993 in the Senate
- Last action
- March 11, 1994
Sponsors
Prime sponsor: R. Lorraine Wojahn (D-27)
3 co-sponsors (1 Democrat, 2 Republicans)
Votes
No recorded floor votes. This measure never reached a floor vote.
History
The Legislature's online data doesn't include step-by-step history for sessions before 2001. Its final status is shown above, and the official bill page may have more.
SJM 8007 in other sessions
Bill numbers restart every two years, so the same number is a different bill in each session.
- SJM 8007 (2025–26) Nuclear war checks, balances
- SJM 8007 (2023–24) IDEA funding
- SJM 8007 (2021–22) Spent nuclear fuel
- SJM 8007 (2019–20) Constitutional convention
- SJM 8007 (2017–18) United States mail service
- SJM 8007 (2015–16) PS hatchery & gen mgmt plans
- SJM 8007 (2013–14) Harbor maintenance tax
- SJM 8007 (2011–12) Corporations